CAMBRIDGE, Mass., May 15, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (FULC) ® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results